1.
Marianna B. Ruzinova, Yi-Shan Lee, Eric J. Duncavage, John S. Welch. TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies. haematol [Internet]. 2019Jul.31 [cited 2024Nov.25];104(8):e345-e348. Available from: https://haematologica.org/article/view/9021